Parallel Advisors, LLC Cor Medix Inc. Transaction History

Parallel Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$4.08 - $6.39 $1,015 - $1,591	249 New	249 $1,000
Q1 2021 Apr 23, 2021	SELL	$6.84 - $17.58 $23,769 - $61,090	-3,475 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$5.0 - $9.15 $1,360 - $2,488	-272 Reduced 7.26%	3,475 $26,000
Q3 2019 Nov 01, 2019	BUY	$6.38 - $9.69 $23,905 - $36,308	3,747 New	3,747 $24,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.